Cargando…
A Multilevel Approach to Stakeholder Engagement in the Formulation of a Clinical Data Research Network
OBJECTIVES: To ensure meaningful engagement of stakeholders (patients, clinicians, and communities) in developing the Mid-South Clinical Data Research Network (MS-CDRN), we implemented a comprehensive, multilevel approach: (1) identify barriers to involving stakeholders in governance, network design...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6136953/ https://www.ncbi.nlm.nih.gov/pubmed/30074947 http://dx.doi.org/10.1097/MLR.0000000000000778 |
_version_ | 1783355093747236864 |
---|---|
author | Boyer, Alaina P. Fair, Alecia M. Joosten, Yvonne A. Dolor, Rowena J. Williams, Neely A. Sherden, Lisa Stallings, Sarah Smoot, Duane T. Wilkins, Consuelo H. |
author_facet | Boyer, Alaina P. Fair, Alecia M. Joosten, Yvonne A. Dolor, Rowena J. Williams, Neely A. Sherden, Lisa Stallings, Sarah Smoot, Duane T. Wilkins, Consuelo H. |
author_sort | Boyer, Alaina P. |
collection | PubMed |
description | OBJECTIVES: To ensure meaningful engagement of stakeholders (patients, clinicians, and communities) in developing the Mid-South Clinical Data Research Network (MS-CDRN), we implemented a comprehensive, multilevel approach: (1) identify barriers to involving stakeholders in governance, network design, and implementation; (2) engage stakeholders in priority setting and research topic generation; (3) develop strategies to fully integrate stakeholders in CDRN governance and oversight; and (4) solicit guidance on patient-centered tools and strategies for recruiting research participants. METHODS: We engaged stakeholders: (1) as integral research team members; (2) on oversight and advisory committees; (3) as consultants (using Community Engagement Studios); and (4) through interviews and surveys. We recruited stakeholders from community health centers, churches, barbershops, health fairs, a volunteer registry, and a patient portal. We prioritized recruitment from populations often underrepresented in research. RESULTS: During the first 18 months, we engaged 5670 stakeholders in developing the MS-CDRN. These were research team members and on governance committees (N=10), consultants (N=58), survey respondents (N=5543), and interviewees (N=59). Stakeholders identified important barriers and facilitators to engagement, developed stakeholder-informed policies, provided feedback on priority topics and research questions, and developed an intake process for data requests and interventional studies that included reviewing for appropriate patient-centeredness, patient engagement, and dissemination. DISCUSSION: Multilevel stakeholder engagement is a novel systematic approach to developing a meaningful patient-centered and patient-engaged research program. This approach allows ongoing input from highly engaged stakeholders while leveraging focused input from larger, more diverse groups to enhance the patient-centeredness of research and increase relevance to broader audiences. |
format | Online Article Text |
id | pubmed-6136953 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | Lippincott Williams & Wilkins |
record_format | MEDLINE/PubMed |
spelling | pubmed-61369532018-09-28 A Multilevel Approach to Stakeholder Engagement in the Formulation of a Clinical Data Research Network Boyer, Alaina P. Fair, Alecia M. Joosten, Yvonne A. Dolor, Rowena J. Williams, Neely A. Sherden, Lisa Stallings, Sarah Smoot, Duane T. Wilkins, Consuelo H. Med Care Original Articles OBJECTIVES: To ensure meaningful engagement of stakeholders (patients, clinicians, and communities) in developing the Mid-South Clinical Data Research Network (MS-CDRN), we implemented a comprehensive, multilevel approach: (1) identify barriers to involving stakeholders in governance, network design, and implementation; (2) engage stakeholders in priority setting and research topic generation; (3) develop strategies to fully integrate stakeholders in CDRN governance and oversight; and (4) solicit guidance on patient-centered tools and strategies for recruiting research participants. METHODS: We engaged stakeholders: (1) as integral research team members; (2) on oversight and advisory committees; (3) as consultants (using Community Engagement Studios); and (4) through interviews and surveys. We recruited stakeholders from community health centers, churches, barbershops, health fairs, a volunteer registry, and a patient portal. We prioritized recruitment from populations often underrepresented in research. RESULTS: During the first 18 months, we engaged 5670 stakeholders in developing the MS-CDRN. These were research team members and on governance committees (N=10), consultants (N=58), survey respondents (N=5543), and interviewees (N=59). Stakeholders identified important barriers and facilitators to engagement, developed stakeholder-informed policies, provided feedback on priority topics and research questions, and developed an intake process for data requests and interventional studies that included reviewing for appropriate patient-centeredness, patient engagement, and dissemination. DISCUSSION: Multilevel stakeholder engagement is a novel systematic approach to developing a meaningful patient-centered and patient-engaged research program. This approach allows ongoing input from highly engaged stakeholders while leveraging focused input from larger, more diverse groups to enhance the patient-centeredness of research and increase relevance to broader audiences. Lippincott Williams & Wilkins 2018-10 2018-09-13 /pmc/articles/PMC6136953/ /pubmed/30074947 http://dx.doi.org/10.1097/MLR.0000000000000778 Text en Copyright © 2018 The Author(s). Published by Wolters Kluwer Health, Inc This is an open access article distributed under the Creative Commons Attribution License 4.0 (http://creativecommons.org/licenses/by/4.0/) (CCBY), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. http://creativecommons.org/licenses/by/4.0/ |
spellingShingle | Original Articles Boyer, Alaina P. Fair, Alecia M. Joosten, Yvonne A. Dolor, Rowena J. Williams, Neely A. Sherden, Lisa Stallings, Sarah Smoot, Duane T. Wilkins, Consuelo H. A Multilevel Approach to Stakeholder Engagement in the Formulation of a Clinical Data Research Network |
title | A Multilevel Approach to Stakeholder Engagement in the Formulation of a Clinical Data Research Network |
title_full | A Multilevel Approach to Stakeholder Engagement in the Formulation of a Clinical Data Research Network |
title_fullStr | A Multilevel Approach to Stakeholder Engagement in the Formulation of a Clinical Data Research Network |
title_full_unstemmed | A Multilevel Approach to Stakeholder Engagement in the Formulation of a Clinical Data Research Network |
title_short | A Multilevel Approach to Stakeholder Engagement in the Formulation of a Clinical Data Research Network |
title_sort | multilevel approach to stakeholder engagement in the formulation of a clinical data research network |
topic | Original Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6136953/ https://www.ncbi.nlm.nih.gov/pubmed/30074947 http://dx.doi.org/10.1097/MLR.0000000000000778 |
work_keys_str_mv | AT boyeralainap amultilevelapproachtostakeholderengagementintheformulationofaclinicaldataresearchnetwork AT fairaleciam amultilevelapproachtostakeholderengagementintheformulationofaclinicaldataresearchnetwork AT joostenyvonnea amultilevelapproachtostakeholderengagementintheformulationofaclinicaldataresearchnetwork AT dolorrowenaj amultilevelapproachtostakeholderengagementintheformulationofaclinicaldataresearchnetwork AT williamsneelya amultilevelapproachtostakeholderengagementintheformulationofaclinicaldataresearchnetwork AT sherdenlisa amultilevelapproachtostakeholderengagementintheformulationofaclinicaldataresearchnetwork AT stallingssarah amultilevelapproachtostakeholderengagementintheformulationofaclinicaldataresearchnetwork AT smootduanet amultilevelapproachtostakeholderengagementintheformulationofaclinicaldataresearchnetwork AT wilkinsconsueloh amultilevelapproachtostakeholderengagementintheformulationofaclinicaldataresearchnetwork AT boyeralainap multilevelapproachtostakeholderengagementintheformulationofaclinicaldataresearchnetwork AT fairaleciam multilevelapproachtostakeholderengagementintheformulationofaclinicaldataresearchnetwork AT joostenyvonnea multilevelapproachtostakeholderengagementintheformulationofaclinicaldataresearchnetwork AT dolorrowenaj multilevelapproachtostakeholderengagementintheformulationofaclinicaldataresearchnetwork AT williamsneelya multilevelapproachtostakeholderengagementintheformulationofaclinicaldataresearchnetwork AT sherdenlisa multilevelapproachtostakeholderengagementintheformulationofaclinicaldataresearchnetwork AT stallingssarah multilevelapproachtostakeholderengagementintheformulationofaclinicaldataresearchnetwork AT smootduanet multilevelapproachtostakeholderengagementintheformulationofaclinicaldataresearchnetwork AT wilkinsconsueloh multilevelapproachtostakeholderengagementintheformulationofaclinicaldataresearchnetwork |